학술논문
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10
Document Type
Article
Author
Source
In Gynecologic Oncology February 2015 136(2):212-217
Subject
Language
ISSN
0090-8258